Impact of HIV-1 Membrane Cholesterol on Cell-Independent Lytic Inactivation and Cellular Infectivity

Biochemistry

Volumn 55, Issue 3, 2016, Pages 447-458

  Kalyana Sundaram, Ramalingam Venkat ^a,b   Li, Huiyuan ^c   Bailey, Lauren ^a   Rashad, Adel A ^a   Aneja, Rachna ^a   Weiss, Karl ^d   Huynh, James ^b   Bastian, Arangaserry Rosemary ^a,b,e   Papazoglou, Elisabeth ^b   Abrams, Cameron ^d   Wrenn, Steven ^d   Chaiken, Irwin ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b DREXEL UNIVERSITY   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

^d Drexel University   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; CHOLESTEROL; ENERGY BARRIERS; LIPIDS; MEMBRANES; PROTEINS; TEMPERATURE DISTRIBUTION; VIRUSES;

BETA-CYCLODEXTRIN; CHOLESTEROL DEPLETION; MEMBRANE CHOLESTEROL; MEMBRANE DESTABILIZATION; PARTIAL DEPLETION; PROTEIN FACTORS; TEMPERATURE DEPENDENCE; VIRUS INACTIVATION;

DISEASES;

CHOLESTEROL; GAG PROTEIN; METHYL BETA CYCLODEXTRIN; PEPTIDE TRIAZOLE THIOL DERIVATIVE; STEROL; THIOL DERIVATIVE; UNCLASSIFIED DRUG; BETA CYCLODEXTRIN DERIVATIVE; GLYCOPROTEIN GP 120; KR-13 PEPTIDE; MEMBRANE LIPID; METHYL-BETA-CYCLODEXTRIN; P24 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; PEPTIDE; THIAZOLE DERIVATIVE; TRIAZOLE DERIVATIVE;

ARTICLE; CELL FUSION; CONTROLLED STUDY; CYTOLYSIS; ENERGY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; TEMPERATURE DEPENDENCE; VIRUS ENVELOPE; CHEMISTRY; DRUG EFFECTS; HUMAN; MEMBRANE FLUIDITY; METABOLISM; PATHOGENICITY; PHYSIOLOGY; TUMOR CELL LINE;

BETA-CYCLODEXTRINS; CELL LINE, TUMOR; CHOLESTEROL; HIV CORE PROTEIN P24; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MEMBRANE FLUIDITY; MEMBRANE LIPIDS; PEPTIDES; SULFHYDRYL COMPOUNDS; THIAZOLES; TRIAZOLES;

EID: 84956783015     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/acs.biochem.5b00936     Document Type: Article

References (47)

1. Helseth, E., Kowalski, M., Gabuzda, D., Olshevsky, U., Haseltine, W., and Sodroski, J. (1990) Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants J. Virol. 64, 2416-2420
2. Blumenthal, R., Durell, S., and Viard, M. (2012) HIV entry and envelope glycoprotein-mediated fusion J. Biol. Chem. 287, 40841-40849 10.1074/jbc.R112.406272
3. Gopi, H., Cocklin, S., Pirrone, V., McFadden, K., Tuzer, F., Zentner, I., Ajith, S., Baxter, S., Jawanda, N., Krebs, F. C., and Chaiken, I. M. (2009) Introducing metallocene into a triazole peptide conjugate reduces its off-rate and enhances its affinity and antiviral potency for HIV-1 gp120 J. Mol. Recognit. 22, 169-174 10.1002/jmr.892
4. Bastian, A. R., Contarino, M., Bailey, L. D., Aneja, R., Moreira, D. R., Freedman, K., McFadden, K., Duffy, C., Emileh, A., Leslie, G., Jacobson, J. M., Hoxie, J. A., and Chaiken, I. (2013) Interactions of peptide triazole thiols with Env gp120 induce irreversible breakdown and inactivation of HIV-1 virions Retrovirology 10, 153 10.1186/1742-4690-10-153
5. Bastian, A. R., Kantharaju, McFadden, K., Duffy, C., Rajagopal, S., Contarino, M. R., Papazoglou, E., and Chaiken, I. (2011) Cell-free HIV-1 virucidal action by modified peptide triazole inhibitors of Env gp120 ChemMedChem 6, 1335-1339 10.1002/cmdc.201100177
6. Brugger, B., Glass, B., Haberkant, P., Leibrecht, I., Wieland, F. T., and Krausslich, H. G. (2006) The HIV lipidome: A raft with an unusual composition Proc. Natl. Acad. Sci. U. S. A. 103, 2641-2646 10.1073/pnas.0511136103
7. Chan, R., Uchil, P. D., Jin, J., Shui, G., Ott, D. E., Mothes, W., and Wenk, M. R. (2008) Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides J. Virol. 82, 11228-11238 10.1128/JVI.00981-08
8. Lorizate, M., Sachsenheimer, T., Glass, B., Habermann, A., Gerl, M. J., Krausslich, H. G., and Brugger, B. (2013) Comparative lipidomics analysis of HIV-1 particles and their producer cell membrane in different cell lines Cell. Microbiol. 15, 292-304 10.1111/cmi.12101
9. Louder, M. K., Sambor, A., Chertova, E., Hunte, T., Barrett, S., Ojong, F., Sanders-Buell, E., Zolla-Pazner, S., McCutchan, F. E., Roser, J. D., Gabuzda, D., Lifson, J. D., and Mascola, J. R. (2005) HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity Virology 339, 226-238 10.1016/j.virol.2005.06.003
10. He, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D. O., and Landau, N. R. (1995) Human immunodeficiency virus type 1 viral protein R (VPR) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity J. Virol. 69, 6705-6711
11. Connor, R. I., Chen, B. K., Choe, S., and Landau, N. R. (1995) Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes Virology 206, 935-944 10.1006/viro.1995.1016
12. Domanska, M. K., Wrona, D., and Kasson, P. M. (2013) Multiphasic effects of cholesterol on influenza fusion kinetics reflect multiple mechanistic roles Biophys. J. 105, 1383-1387 10.1016/j.bpj.2013.08.003
13. Campbell, S., Gaus, K., Bittman, R., Jessup, W., Crowe, S., and Mak, J. (2004) The raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated Brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity J. Virol. 78, 10556-10565 10.1128/JVI.78.19.10556-10565.2004
14. Umashankara, M., McFadden, K., Zentner, I., Schon, A., Rajagopal, S., Tuzer, F., Kuriakose, S. A., Contarino, M., Lalonde, J., Freire, E., and Chaiken, I. (2010) The active core in a triazole peptide dual-site antagonist of HIV-1 gp120 ChemMedChem 5, 1871-1879 10.1002/cmdc.201000222
15. Montefiori, D. C. (2005) Evaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays Curr. Prot. Immunol. 64, 12.11.11-12.11.17 10.1002/0471142735.im1211s64
16. Booth, A. M., Fang, Y., Fallon, J. K., Yang, J. M., Hildreth, J. E., and Gould, S. J. (2006) Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane J. Cell Biol. 172, 923-935 10.1083/jcb.200508014
17. Crooks, E. T., Tong, T., Osawa, K., and Binley, J. M. (2011) Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected J. Virol. 85, 5825-5839 10.1128/JVI.00154-11
18. Lorizate, M., Brugger, B., Akiyama, H., Glass, B., Muller, B., Anderluh, G., Wieland, F. T., and Krausslich, H. G. (2009) Probing HIV-1 membrane liquid order by Laurdan staining reveals producer cell-dependent differences J. Biol. Chem. 284, 22238-22247 10.1074/jbc.M109.029256
19. McIntosh, A. L., Atshaves, B. P., Huang, H., Gallegos, A. M., Kier, A. B., and Schroeder, F. (2008) Fluorescence techniques using dehydroergosterol to study cholesterol trafficking Lipids 43, 1185-1208 10.1007/s11745-008-3194-1
20. Chong, P. L. (1994) Evidence for regular distribution of sterols in liquid crystalline phosphatidylcholine bilayers Proc. Natl. Acad. Sci. U. S. A. 91, 10069-10073 10.1073/pnas.91.21.10069
21. Mukherjee, S., Zha, X. H., Tabas, I., and Maxfield, F. R. (1998) Cholesterol distribution in living cells: Fluorescence imaging using dehydroergosterol as a fluorescent cholesterol analog Biophys. J. 75, 1915-1925 10.1016/S0006-3495(98)77632-5
22. Wustner, D., Herrmann, A., Hao, M. M., and Maxfield, F. R. (2002) Rapid nonvesicular transport of sterol between the plasma membrane domains of polarized hepatic cells J. Biol. Chem. 277, 30325-30336 10.1074/jbc.M202626200
23. Graham, D. R., Chertova, E., Hilburn, J. M., Arthur, L. O., and Hildreth, J. E. (2003) Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts J. Virol. 77, 8237-8248 10.1128/JVI.77.15.8237-8248.2003
24. Thorp, E. B. and Gallagher, T. M. (2004) Requirements for CEACAMs and cholesterol during murine coronavirus cell entry J. Virol. 78, 2682-2692 10.1128/JVI.78.6.2682-2692.2004
25. Bourguignon, L. Y., Singleton, P. A., Diedrich, F., Stern, R., and Gilad, E. (2004) CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion J. Biol. Chem. 279, 26991-27007 10.1074/jbc.M311838200
26. Eskelinen, E. L., Schmidt, C. K., Neu, S., Willenborg, M., Fuertes, G., Salvador, N., Tanaka, Y., Lullmann-Rauch, R., Hartmann, D., Heeren, J., von Figura, K., Knecht, E., and Saftig, P. (2004) Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts Mol. Biol. Cell 15, 3132-3145 10.1091/mbc.E04-02-0103
27. Nilsson, A. (1969) The presence of spingomyelin- and ceramide-cleaving enzymes in the small intestinal tract Biochim. Biophys. Acta, Lipids Lipid Metab. 176, 339-347 10.1016/0005-2760(69)90192-1
28. López, C. A., de Vries, A. H., and Marrink, S. J. (2013) Computational microscopy of cyclodextrin mediated cholesterol extraction from lipid model membranes Sci. Rep. 3 2071 10.1038/srep02071
29. Liao, Z., Cimakasky, L. M., Hampton, R., Nguyen, D. H., and Hildreth, J. E. (2001) Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1 AIDS Res. Hum. Retroviruses 17, 1009-1019 10.1089/088922201300343690
30. Liao, Z., Graham, D. R., and Hildreth, J. E. (2003) Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells AIDS Res. Hum. Retroviruses 19, 675-687 10.1089/088922203322280900
31. Tong, T., Crooks, E. T., Osawa, K., and Binley, J. M. (2012) HIV-1 virus-like particles bearing pure env trimers expose neutralizing epitopes but occlude nonneutralizing epitopes J. Virol. 86, 3574-3587 10.1128/JVI.06938-11
32. Xu, X. and London, E. (2000) The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation Biochemistry 39, 843-849 10.1021/bi992543v
33. Aloia, R. C., Jensen, F. C., Curtain, C. C., Mobley, P. W., and Gordon, L. M. (1988) Lipid composition and fluidity of the human immunodeficiency virus Proc. Natl. Acad. Sci. U. S. A. 85, 900-904 10.1073/pnas.85.3.900
34. Aloia, R. C., Tian, H., and Jensen, F. C. (1993) Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes Proc. Natl. Acad. Sci. U. S. A. 90, 5181-5185 10.1073/pnas.90.11.5181
35. Smutzer, G., Crawford, B. F., and Yeagle, P. L. (1986) Physical properties of the fluorescent sterol probe dehydroergosterol Biochim. Biophys. Acta, Biomembr. 862, 361-371 10.1016/0005-2736(86)90239-7
36. Yamamoto, M., Aizaki, H., Fukasawa, M., Teraoka, T., Miyamura, T., Wakita, T., and Suzuki, T. (2011) Structural requirements of virion-associated cholesterol for infectivity, buoyant density and apolipoprotein association of hepatitis C virus J. Gen. Virol. 92, 2082-2087 10.1099/vir.0.032391-0
37. Brandenberg, O. F., Magnus, C., Rusert, P., Regoes, R. R., and Trkola, A. (2015) Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entry PLoS Pathog. 11, e1004595 10.1371/journal.ppat.1004595
38. Simons, K. and Ikonen, E. (1997) Functional rafts in cell membranes Nature 387, 569-572 10.1038/42408
39. Lingwood, D. and Simons, K. (2010) Lipid rafts as a membrane-organizing principle Science 327, 46-50 10.1126/science.1174621
40. Nguyen, D. H. and Taub, D. (2002) Cholesterol is essential for macrophage inflammatory protein 1 beta binding and conformational integrity of CC chemokine receptor 5 Blood 99, 4298-4306 10.1182/blood-2001-11-0087
41. Pontier, S. M., Percherancier, Y., Galandrin, S., Breit, A., Gales, C., and Bouvier, M. (2008) Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction J. Biol. Chem. 283, 24659-24672 10.1074/jbc.M800778200
42. Pucadyil, T. J. and Chattopadhyay, A. (2004) Cholesterol modulates ligand binding and G-protein coupling to serotonin(1A) receptors from bovine hippocampus Biochim. Biophys. Acta, Biomembr. 1663, 188-200 10.1016/j.bbamem.2004.03.010
43. Klein, U., Gimpl, G., and Fahrenholz, F. (1995) Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor Biochemistry 34, 13784-13793 10.1021/bi00042a009
44. Epand, R. F., Sayer, B. G., and Epand, R. M. (2005) The tryptophan-rich region of HIV gp41 and the promotion of cholesterol-rich domains Biochemistry 44, 5525-5531 10.1021/bi0500224
45. Epand, R. F., Thomas, A., Brasseur, R., Vishwanathan, S. A., Hunter, E., and Epand, R. M. (2006) Juxtamembrane protein segments that contribute to recruitment of cholesterol into domains Biochemistry 45, 6105-6114 10.1021/bi060245+
46. Bavari, S., Bosio, C. M., Wiegand, E., Ruthel, G., Will, A. B., Geisbert, T. W., Hevey, M., Schmaljohn, C., Schmaljohn, A., and Aman, M. J. (2002) Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses J. Exp. Med. 195, 593-602 10.1084/jem.20011500
47. Carro, A. C. and Damonte, E. B. (2013) Requirement of cholesterol in the viral envelope for dengue virus infection Virus Res. 174, 78-87 10.1016/j.virusres.2013.03.005